← Leaderboards
Kathryn C. Fitzgerald
Johns Hopkins University
$3,287,477
Attributed
$3,896,306
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2019–25$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,896,306 · 5
By mechanism
R01$1,225,466 · 1
U01$1,217,659 · 1
K01$675,368 · 1
R21$450,313 · 1
R03$327,500 · 1
Top collaborators
- Peter A Calabresi1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Peter A Calabresi$20,846,075
- Linda P Fried$18,538,317
- Gail L Daumit$28,900,560
- Melania Maria Bembea$4,528,092
- John H. Kempen$14,361,889
Others in their field
Other Emerging Leaders on “Inflammatory”
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$21,969,486
- Gary Fanger · Rise Therapeutics, Llc$20,823,569
- Gina Montealegre · Leidos Biomedical Research, Inc.$19,781,641
- Jeffrey Reich · Sparian Biosciences, Inc.$13,729,307
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$11,846,278
- James Dale Berry · Brigham And Women'S Hospital$11,004,714
Research focus
InflammatoryFutureNeurodegenerative DisordersInsightMultiple SclerosisBiologicalDisabilityCentral Nervous System DiseasesMediatingMultiple Sclerosis PatientLightHigh RiskChronicEtiologyDisorder RiskLinkCostStandardizationInnovationHourPathway InteractionsCircadianCircadian RhythmsMorbidity - Disease Rate
Grant awards (11)
Metabolic predictors of disease outcomes in multiple sclerosis$575,637
R01 · FY2025 · NS · contact PI
Repurposing Existing Therapies for Parkinson's Disease Risk and Phenoconversion$286,563
R21 · FY2025 · NS · contact PI
Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis$1,217,659
U01 · FY2024 · NS · contact PI
Metabolic predictors of disease outcomes in multiple sclerosis$649,829
R01 · FY2024 · NS · contact PI
Repurposing Existing Therapies for Parkinson's Disease Risk and Phenoconversion$163,750
R21 · FY2024 · NS · contact PI
Circadian Rhythms and Sleep, Structural Neuroimaging and Depression in People with Multiple Sclerosis$179,283
K01 · FY2022 · MH · contact PI
Circadian Rhythms and Sleep, Structural Neuroimaging and Depression in People with Multiple Sclerosis$179,283
K01 · FY2021 · MH · contact PI
Bright Light Therapy for Sleep Disturbance in Multiple Sclerosis$163,750
R03 · FY2021 · HD · contact PI
Bright Light Therapy for Sleep Disturbance in Multiple Sclerosis$163,750
R03 · FY2020 · HD · contact PI
Circadian Rhythms and Sleep, Structural Neuroimaging and Depression in People with Multiple Sclerosis$158,401
K01 · FY2020 · MH · contact PI
Circadian Rhythms and Sleep, Structural Neuroimaging and Depression in People with Multiple Sclerosis$158,401
K01 · FY2019 · MH · contact PI